tiprankstipranks
Trending News
More News >
Cryofocus Medtech (Shanghai) Co. Ltd. Class H (HK:6922)
:6922
Hong Kong Market
Advertisement

Cryofocus Medtech (Shanghai) Co. Ltd. Class H (6922) Price & Analysis

Compare
1 Followers

6922 Stock Chart & Stats


Cryofocus Medtech (Shanghai) Co. Ltd. Class H News

6922 FAQ

What was Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s price range in the past 12 months?
Cryofocus Medtech (Shanghai) Co. Ltd. Class H lowest stock price was HK$3.20 and its highest was HK$14.02 in the past 12 months.
    What is Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s market cap?
    Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s market cap is HK$1.55B.
      When is Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s upcoming earnings report date?
      Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s upcoming earnings report date is Mar 26, 2026 which is in 165 days.
        How were Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s earnings last quarter?
        Cryofocus Medtech (Shanghai) Co. Ltd. Class H released its earnings results on Aug 08, 2025. The company reported -HK$0.107 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.107.
          Is Cryofocus Medtech (Shanghai) Co. Ltd. Class H overvalued?
          According to Wall Street analysts Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Cryofocus Medtech (Shanghai) Co. Ltd. Class H pay dividends?
            Cryofocus Medtech (Shanghai) Co. Ltd. Class H does not currently pay dividends.
            What is Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s EPS estimate?
            Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cryofocus Medtech (Shanghai) Co. Ltd. Class H have?
            Cryofocus Medtech (Shanghai) Co. Ltd. Class H has 143,438,580 shares outstanding.
              What happened to Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s price movement after its last earnings report?
              Cryofocus Medtech (Shanghai) Co. Ltd. Class H reported an EPS of -HK$0.107 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.685%.
                Which hedge fund is a major shareholder of Cryofocus Medtech (Shanghai) Co. Ltd. Class H?
                Currently, no hedge funds are holding shares in HK:6922

                Cryofocus Medtech (Shanghai) Co. Ltd. Class H Stock Smart Score

                4
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                -18.89%
                12-Months-Change

                Fundamentals

                Return on Equity
                -86.71%
                Trailing 12-Months
                Asset Growth
                -11.77%
                Trailing 12-Months

                Cryofocus Medtech (Shanghai) Co. Ltd. Class H (6922) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                JW (Cayman) Therapeutics Co. Ltd.
                Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
                Broncus Holding Corp.
                Venus Medtech (Hangzhou), Inc. Class H
                Shanghai Heartcare Medical Technology Corp. Ltd. Class H
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis